iSpecimen Inc. - ISPC
Sector:
Healthcare
· Industry:
Diagnostics & Research
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$87K
QoQ value delta ($000)
+$60K
(+222.22%)
Implied price effect (QoQ)
-27.25%
Shares
Total shares
560,982
QoQ shares delta
+434,327
(+342.92%)
Total shares held by funds (by quarter)
Market chart (ISPC)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 12 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 49 | 313,098 | 0.0% |
| JANE STREET GROUP, LLC | 8 | 55,631 | 0.0% |
| UBS Group AG | 8 | 53,744 | 0.0% |
| VANGUARD GROUP INC | 7 | 29,407 | 0.0% |
| CITADEL ADVISORS LLC | 7 | 50,471 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 4 | 28,170 | 0.0% |
| StoneX Group Inc. | 3 | 19,710 | 0.0% |
| Tower Research Capital LLC (TRC) | 1 | 6,651 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 19 | 0.0% |
| Sachetta, LLC | 0 | 2 | 0.0% |
| BlackRock, Inc. | 0 | 2,827 | 0.0% |
| GILL CAPITAL PARTNERS, LLC | 0 | 15 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 0 | 1,237 | 0.0% |